.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Boehringer Ingelheim
Federal Trade Commission
Argus Health
UBS
Fish and Richardson
Julphar
Novartis
Cipla

Generated: February 21, 2018

DrugPatentWatch Database Preview

Drug Master Files for: Par Pharm

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
3441III2/9/1979PAR PHARMACEUTICAL INCFACILITIES AND CONTROLS
5963III8/8/1985PAR PHARMACEUTICAL INCMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SPRING VALLEY, NEW YORK.
25462AII12/14/2011PAR PHARMACEUTICAL INCPIMOZIDE USP
25580AII1/11/2012PAR PHARMACEUTICAL INCPHENOXYBENZAMINE HYDROCHLORIDE USP
25857AII6/13/2012PAR PHARMACEUTICAL INCTOLCAPONE, USP
27125AII7/3/2013PAR PHARMACEUTICAL INCGLYCEROL PHENYLBUTYRATE
27378AII9/16/2013PAR PHARMACEUTICAL INCALOSETRON HYDROCHLORIDE
27722AII12/6/2013PAR PHARMACEUTICAL INCCOLCHICINE USP
28175AII5/15/2014PAR PHARMACEUTICAL INCFERRIC CITRATE
28176AII4/18/2014PAR PHARMACEUTICAL INCTIZANIDINE HYDROCHLORIDE, USP
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Moodys
AstraZeneca
Johnson and Johnson
McKesson
UBS
US Army
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot